These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 402526)

  • 1. Interactions of thyrotropin releasing hormone and morphine sulfate in rodents.
    Martin BR; Dewey WL; Chau-Pham T; Prnage AJ
    Life Sci; 1977 Feb; 20(4):715-22. PubMed ID: 402526
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyrotropin (TSH) response to synthetic TSH-releasing factor following pharmacological blockade of adrenocorticotropin (ACTH) secretion.
    Koch B; Jobin M; Dulac S; Fortier C
    Can J Physiol Pharmacol; 1972 Apr; 50(4):360-3. PubMed ID: 4338891
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral studies of shaking behavior induced by thyrotropin-releasing hormone and morphine withdrawal in rats.
    Yamada K; Matsuki J; Ushijima I; Inoue T; Furukawa T
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):24-33. PubMed ID: 6307193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thydrotropin releasing hormone: antagonism of pentobarbital in rodents.
    Prange AJ; Breese GR; Cott JM; Martin BR; Cooper BR; Wilson IC; Plotnikoff NP
    Life Sci; 1974 Feb; 14(3):447-55. PubMed ID: 4207373
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of morphine and chlorpromazine on apomorphine-induced stereotyped behavior.
    McKenzie GM; Sadof M
    J Pharm Pharmacol; 1974 Apr; 26(4):280-2. PubMed ID: 4151388
    [No Abstract]   [Full Text] [Related]  

  • 6. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
    Fraser HF
    Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of thyrotropin-releasing hormone on prolactin, growth hormone and corticosterone secretions in adult male rats treated with pentobarbital or morphine.
    Collu R; Clermont MJ; Ducharme JR
    Eur J Pharmacol; 1976 May; 37(1):133-40. PubMed ID: 819277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the rat.
    Cicero TJ; Meyer ER; Bell RD
    Neuropharmacology; 1974 Jul; 13(7):601-7. PubMed ID: 4155053
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine.
    Hill HE; Bell EC; Wikler A
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the physical dependence potential of analgesics.
    Murano T; Senda H; Yamamoto H; Yano I
    Jpn J Pharmacol; 1978 Jun; 28(3):403-12. PubMed ID: 568188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioral effects of chlorpromazine alone and in combination with different morphine treatments in rats.
    Lucot JB; McMillan DE; Leander JD
    J Pharmacol Exp Ther; 1979 Jan; 208(1):67-72. PubMed ID: 569698
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of thyrotropin releasing hormone (TRH, microinjected into various areas of conscious and pentobarbital-pretreated rabbits.
    Horita A; Carino MA; Weick BG
    Proc West Pharmacol Soc; 1976; 19():212-3. PubMed ID: 825872
    [No Abstract]   [Full Text] [Related]  

  • 13. Assays for corticotropin-releasing factor (CRF) using rats treated with morphine, chlorpromazine, dexamethasone and Nembutal.
    Arimura A; Saito T; Schally AV
    Endocrinology; 1967 Aug; 81(2):235-45. PubMed ID: 4951998
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
    Mattila MJ; Alhava E; Mansner R
    Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacologic changes in feeding behavior: food intake and rumination in sheep].
    Ruckebusch Y; Laplace JP
    Psychopharmacologia; 1968; 12(2):104-14. PubMed ID: 5657046
    [No Abstract]   [Full Text] [Related]  

  • 16. Antinociceptive properties of thyrotropin releasing hormone in mice: comparison with morphine.
    Boschi G; Desiles M; Reny V; Rips R; Wrigglesworth S
    Br J Pharmacol; 1983 May; 79(1):85-92. PubMed ID: 6409194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermia and antinociceptive activity of thyrotropin-releasing hormone and morphine following central administration in rats.
    Zhukov VN; Yakimova KS; Shamyakina IY
    Acta Physiol Pharmacol Bulg; 1988; 14(2):18-23. PubMed ID: 3146885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative ontogeny of opioid and catecholaminergic regulation of thyrotropin secretion in the rat.
    Ignar DM; Kuhn CM
    Endocrinology; 1988 Jul; 123(1):567-71. PubMed ID: 3133201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of thyrotropin-releasing factor (TRF); interaction with some antipsychotic drugs.
    Mora S; Loizzo A; Longo VG
    Pharmacol Biochem Behav; 1976 Mar; 4(3):279-82. PubMed ID: 819939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.